Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women

European Journal of Endocrinology

Volumn 152, Issue 3, 2005, Pages 395-401

  Hohmann, Femke P ^a   Laven, Joop S E ^a   de Jong, Frank H ^a   Fauser, Bart C J M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; FOLLITROPIN; INHIBIN A; INHIBIN B; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DRUG MEGADOSE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; NORMAL HUMAN; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; INHIBINS; OSMOLAR CONCENTRATION; OVARIAN FOLLICLE; OVULATION INDUCTION; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 15944370564     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01871     Document Type: Article

References (40)

1. Burger HG. Evidence for a negative feedback role of inhibin in follicle stimulating hormone regulation in women. Human Reproduction 1993 8 (Suppl 2) 129-132.
2. de Kretser DM, Hedger MP, Loveland KL & Phillips DJ. Inhibins, activins and follistatin in reproduction. Human Reproduction Update 2002 8 529-541.
3. Laven JS & Fauser BC. Inhibins and adult ovarian function. Molecular and Cellular Endocrinology 2004 225 37-44.
4. Roberts VJ, Barth S, el Roeiy A & Yen SS. Expression of inhibin/ activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1993 77 1402-1410.
5. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP & McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1996 81 1401-1405.
6. Schipper I, de Jong FH & Fauser BC. Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Human Reproduction 1998 13 1442-1448.
7. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR & Knight PG. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Human Reproduction 1994 91634-1642.
8. Brannian JD, Stouffer RL, Molskness TA, Chandrasekher YA, Sarkissian A & Dahl KD. Inhibin production by macaque granulosa cells from pre- and periovulatory follicles: regulation by gonadotropins and prostaglandin E2. Biology of Reproduction 1992 46 451-457.
9. Stouffer RL, Woodruff TK, Dahl KD, Hess DL, Mather JP & Molskness TA. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 1993 77 241-248.
10. Fraser HM & Tsonis CG. Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion. Journal of Endocrinology 1994 142 181-186.
11. Molskness TA, Woodruff TK, Hess DL, Dahl KD & Stouffer RL. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 1996 814002-4006.
12. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT & McNeilly AS. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clinical Endocrinology 1994 40 717-723.
13. Sehested A, Juul AA, Andersson AM, Petersen JH, Jensen TK, Muller J & Skakkebaek NE. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. Journal of Clinical Endocrinology and Metabolism 2000 85 1634-1640.
14. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW & te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertility and Sterility 1999 72 845-851.
15. Soules MR, Battaglia DE & Klein NA. Inhibin and reproductive aging in women. Maturitas 1998 30 193-204.
16. Burger HG. Inhibin and reproductive aging. Experimental Gerontology 2000 35 33-39.
17. McLachlan RI, Robertson DM, Healy DL, de Kretser DM & Burger HG. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet 1986 1 1233-1234.
18. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS & Berk CA. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertility and Sterility 1997 67 110-114.
19. Tinkanen H, Blauer M, Laippala P, Tuohimaa P & Kujansuu E. Prognostic factors in controlled ovarian hyperstimulation. Fertility and Sterility 1999 72 932-936.
20. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA & Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Human Reproduction 2000 15 2341-2346.
21. Dumesic DA, Damario MA, Session DR, Famuyide A, Lesnick TG, Thornhill AR & McNeilly AS. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. Journal of Clinical Endocrinology and Metabolism 2001 86 2538-2543.
22. Lockwood GM, Muttukrishna S, Groome NP, Knight PG & Ledger WL. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clinical Endocrinology 1996 45 741-748.
23. Dzik A, Lambert-Messerlian G, Izzo VM, Soares JB, Pinotti JA & Seifer DB. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertility and Sterility 2000 74 1114-1117.
24. Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G & Winston R. Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Human Reproduction 2000 15 2297-2301.
25. Eldar-Geva T, Robertson DM, Cahir N, Groome N, Gabbe MP, Maclachlan V & Healy DL. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. Journal of Clinical Endocrinology and Metabolism 2000 85 607-613.
26. Fawzy M, Lambert A, Harrison RF, Knight PG, Groome N, Hennelly B & Robertson WR. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Human Reproduction 2002 17 1535-1543.
27. Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WFJ, Smith JA, Schoenfeld DA & Hall JE. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. Journal of Clinical Endocrinology and Metabolism 1997 82 2645-2652.
28. Schipper I, Hop WC & Fauser BC. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. Journal of Clinical Endocrinology and Metabolism 1998 83 1292-1298.
29. Hohmann FP, Laven JS, de Jong FH, Eijkemans MJ & Fauser BC. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Human Reproduction 2001 16846-854.
30. van Santbrink EJ, Hop WC, van Dessel TJ, de Jong FH & Fauser BC. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertility and Sterility 1995 64 37-43.
31. Fauser BC & Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 1997 18 71-106.
32. Pache TD, Wladimiroff JW, de Jong FH, Hop WC & Fauser BC. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertility and Sterility 1990 54 638-642.
33. Baird DT. A model for follicular selection and ovulation: lessons from superovulation. Journal of Steroid Biochemistry and Molecular Biology 1987 27 15-23.
34. Muttukrishna S, George L, Fowler PA, Groome NP & Knight PG. Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clinical Endocrinology 1995 42 391-397.
35. Burger HG, Groome NP & Robertson DM. Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1998 83 4167-4169.
36. Bukman A & Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Human Reproduction Update 2001 7 581-590.
37. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH & Pyrzak R. Relationship of follicle numbers and estradiol levels to multiple implantation in 3608 intrauterine insemination cycles. Fertility and Sterility2001 75 69-78.
38. Tur R, Barri PN, Coroleu B, Buxaderas R, Martinez F & Balasch J. Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Human Reproduction 2001 16 2124-2129.
39. Yong PY, Baird DT, Thong KJ, McNeilly AS & Anderson RA. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Human Reproduction 2003 18 35-44.
40. Hall JE, Welt CK & Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Human Reproduction 1999 14 409-415.